
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Type 2 Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Recipient : Universiti Sains Malaysia
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Mobithron Advance (Type 2 Collagen) is a Protein drug, which is currently being evaluated in Phase I clinical studies for the treatment of Osteoarthritis, Knee.
Product Name : Mobithron Advance
Product Type : Protein
Upfront Cash : Inapplicable
January 07, 2026
Lead Product(s) : Type 2 Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Recipient : Universiti Sains Malaysia
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Alpha Lipoic Acid,Vitamin E,Vitamin B Complex
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Hospital Universiti Sains Malaysia
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Alpha Lipoic Acid is a small molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Carpal Tunnel Syndrome.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 31, 2025
Lead Product(s) : Alpha Lipoic Acid,Vitamin E,Vitamin B Complex
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Hospital Universiti Sains Malaysia
Deal Size : Inapplicable
Deal Type : Inapplicable
